IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, announced today that it presented data during the 2014 International Meeting for Autism Research (IMFAR) held in Atlanta, Georgia reporting the results of a study which permits the ability to predict the risk of autism spectrum disorder (ASD) in children with signs of developmental delay or autism.
Help employers find you! Check out all the jobs and post your resume.
